Single-dose 1cp-LSD administration for canine anxiety: a pilot study.
Veterinary research communications December 1, 2024 Luis Alberto Henríquez-Hernández, Ignacio García-Serrano, Domingo J Quintana-Hernández et al. 4 citations
A single low dose of 1cp-LSD (5 µg, or 0.38 µg/kg) was given orally to a 13-year-old mixed-breed dog with lifelong separation anxiety. For the first two hours the dog remained equally anxious in response to anxiety-inducing stimuli, but after that point its behavior showed a significant change with no or only mild signs of anxiety. The trial lasted five and a half hours and produced no adverse effects; the dog showed no signs of a psychedelic experience. The authors conclude that 1cp-LSD was safe and effectively reduced the dog's anxiety.